A Study of Pembrolizumab and Epacadostat in Recurrent Clear Cell Carcinoma of the Ovary (GY016)
A Study of Pembrolizumab and Epacadostat in Recurrent Clear Cell Carcinoma of the Ovary (GY016)
Trial Category:
Gynecologic
Phase
II
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
This study is looking at new drugs for Clear Cell Cancer of the Ovary that has come back after initial treatment.
